Searched for
SUN PHARMA INSIDER TRADING
500 years buried in a jar, and still intact: The wild story behind Peru's ancient space foodRare Inca freeze-dried potatoes discovery in Peru reveals 500-year-old chuño food system and ancient empire trade intelligence. Archaeologi...- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- SpaceX IPO: Indians queue up to invest more in US stocksSpaceX's blockbuster initial public offering has ignited significant interest among Indian investors in US stocks, with trading volumes on ...
- Scientists just mapped 110 quadrillion kilometers of hidden fungal threads underground, weighing about five times all humans combinedVast underground fungal networks, stretching billions of times to the sun, exist in Earth's soil. These hyphae, finer than hair, weigh more...
- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- World Cup: Does 'False 9' concept has its place in football's biggest theatre?From Gerd Muller to Miroslav Klose and Ronaldo to Harry Kane, the World Cup has traditionally belonged to the strikers who have been the 'K...
- Lucky Day and Unlucky Day of the Week (June 15–21, 2026): Gemini New Moon, Mithuna Sankranti, and Sun Enters Cancer Bring a Powerful Cosmic ResetThe week of June 15-21, 2026, features a powerful astrological shift with a Gemini New Moon and Sun transit on June 15, fostering new begin...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- Sun Transit in Gemini June 2026: Communication, Opportunities & Fast-Paced Growth for Every Zodiac SignThe Sun transit in Gemini on June 15, 2026 brings a noticeable shift toward communication, networking, learning, adaptability, and new oppo...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Kalshi to collect employment info from customers trading in some high-risk marketsKalshi will now assign a score to new markets, and the score will determine how much Kalshi believes that particular market is at risk of i...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Insider trading: Supreme Court upholds SAT clearance to Biocon MDThe Supreme Court has backed a tribunal's decision, clearing Biocon's managing director, Shreehas P Tambe, of insider trading allegations f...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Dalal Street Week Ahead: Will Nifty hold 23,000 as markets test key support?The markets ended lower this week, with Nifty trading below its 50 and 100-week moving averages. While a crucial support zone near 23,000-2...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
Load More
